Literature DB >> 8009963

A role for extracellular matrix degradation and matrix metalloproteinases in senile dementia?

A Bignami1, A LeBlanc, G Perides.   

Abstract

In brain as in cartilage, the extracellular matrix contains aggregates formed by hyaluronic acid (HA) and proteoglycans. In osteoarthritic cartilage, release of the proteoglycans from the aggregates by cleavage of the HA-binding region results in the accumulation of the HA-binding region and in the fragmentation of the released proteoglycans. Stromelysin, a matrix neutral metalloproteinase, is one of the enzymes responsible for the cleavage of the HA-binding region. We suggest that a similar process also occurs in senile dementia. The brain proteoglycan contains sequences identical to those of aggrecan, which are recognized and cleaved by stromelysin, and is, in fact, susceptible to stromelysin digestion. Monoclonal antibodies reacting with glial HA-binding protein, but not with the parent protein, stained several senile plaques as defined by their reactivity with antibodies to the amyloid-beta protein in double-labeling experiments.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8009963     DOI: 10.1007/BF00296747

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

Review 1.  Metalloproteinases and their inhibitors in matrix remodeling.

Authors:  L M Matrisian
Journal:  Trends Genet       Date:  1990-04       Impact factor: 11.639

2.  Brain-specific hyaluronate-binding protein: an immunohistological study with monoclonal antibodies of human and bovine central nervous system.

Authors:  A Bignami; D Dahl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

3.  Aggregation of cartilage proteoglycans. I. The role of hyaluronic acid.

Authors:  V C Hascall; D Heinegård
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

4.  Extracellular matrix of central nervous system white matter: demonstration of an hyaluronate-protein complex.

Authors:  R Asher; G Perides; J J Vanderhaeghen; A Bignami
Journal:  J Neurosci Res       Date:  1991-03       Impact factor: 4.164

5.  Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.

Authors:  A D Snow; H Mar; D Nochlin; R T Sekiguchi; K Kimata; Y Koike; T N Wight
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

6.  Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage.

Authors:  P J Roughley; R J White; A R Poole
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

7.  Isolation of a large aggregating proteoglycan from human brain.

Authors:  G Perides; F Rahemtulla; W S Lane; R A Asher; A Bignami
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

8.  Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins.

Authors:  A J Fosang; P J Neame; T E Hardingham; G Murphy; J A Hamilton
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

9.  Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.

Authors:  J H Su; B J Cummings; C W Cotman
Journal:  Neuroscience       Date:  1992-12       Impact factor: 3.590

10.  Versican, a hyaluronate-binding proteoglycan of embryonal precartilaginous mesenchyma, is mainly expressed postnatally in rat brain.

Authors:  A Bignami; G Perides; F Rahemtulla
Journal:  J Neurosci Res       Date:  1993-01       Impact factor: 4.164

View more
  6 in total

Review 1.  Extracellular matrix degradation by metalloproteinases and central nervous system diseases.

Authors:  A Lukes; S Mun-Bryce; M Lukes; G A Rosenberg
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology.

Authors:  Markus Morawski; Gert Brückner; Carsten Jäger; Gudrun Seeger; Russel T Matthews; Thomas Arendt
Journal:  Brain Pathol       Date:  2012-01-13       Impact factor: 6.508

3.  Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia.

Authors:  A Ghorpade; R Persidskaia; R Suryadevara; M Che; X J Liu; Y Persidsky; H E Gendelman
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein.

Authors:  Jennifer Westling; Paul E Gottschall; Vivian P Thompson; Amber Cockburn; George Perides; Dieter R Zimmermann; John D Sandy
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

5.  Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican?

Authors:  G Perides; R A Asher; M W Lark; W S Lane; R A Robinson; A Bignami
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

6.  Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.

Authors:  Eleanor Drummond; Shruti Nayak; Arline Faustin; Geoffrey Pires; Richard A Hickman; Manor Askenazi; Mark Cohen; Tracy Haldiman; Chae Kim; Xiaoxia Han; Yongzhao Shao; Jiri G Safar; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2017-03-04       Impact factor: 15.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.